1. Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer. Issue 3 (8th December 2014) Authors: Dowling, Paul; Pollard, Damian; Larkin, AnneMarie; Henry, Michael; Meleady, Paula; Gately, Kathy; O'Byrne, Kenneth; Barr, Martin P.; Lynch, Vincent; Ballot, Jo; Crown, John; Moriarty, Michael; O'Brien, Emmet; Morgan, Ross; Clynes, Martin Journal: Molecular bioSystems Issue: Volume 11:Issue 3(2015:Mar.) Page Start: 743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. Issue 2 (February 2015) Authors: Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Or... Journal: Lancet oncology Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. Issue 2 (February 2015) Authors: Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Or... Journal: Lancet oncology Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo. Issue 1 (December 2016) Authors: Cathcart, Mary-Clare; Useckaite, Zivile; Drakeford, Clive; Semik, Vikki; Lysaght, Joanne; Gately, Kathy; O'Byrne, Kenneth; Pidgeon, Graham Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Barrier-to-autointegration-factor (Banf1) modulates DNA double-strand break repair pathway choice via regulation of DNA-dependent kinase (DNA-PK) activity. Issue 6 (28th February 2021) Authors: Burgess, Joshua T; Cheong, Chee Man; Suraweera, Amila; Sobanski, Thais; Beard, Sam; Dave, Keyur; Rose, Maddison; Boucher, Didier; Croft, Laura V; Adams, Mark N; O'Byrne, Kenneth; Richard, Derek J; Bolderson, Emma Journal: Nucleic acids research Issue: Volume 49:Issue 6(2021) Page Start: 3294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial. (September 2017) Authors: Ferry, David; Billingham, Lucinda; Jarrett, Hugh; Dunlop, David; Woll, Penella J.; Nicolson, Marianne; Shah, Riyaz; Thompson, Joyce; Spicer, James; Muthukumar, D.; Skailes, Geraldine; Leonard, Pauline; Chetiyawardana, A.D.; Wells, Paula; Lewanski, Conrad; Crosse, Barbara; Hill, Michelle; Gaunt, P... Journal: European journal of cancer Issue: Volume 83(2017) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Durable complete response to immunotherapy in treatment‐resistant metastatic colorectal cancer with thyroid transcription factor 1 expression. Issue 11 (6th March 2020) Authors: Hanna, Mark; Guerra, Glen; O'Byrne, Kenneth Journal: ANZ journal of surgery Issue: Volume 90:Issue 11(2020) Page Start: E97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. First‐Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases. Issue 3 (March 2016) Authors: Schuler, Martin; Wu, Yi‐Long; Hirsh, Vera; O'Byrne, Kenneth; Yamamoto, Nobuyuki; Mok, Tony; Popat, Sanjay; Sequist, Lecia V.; Massey, Dan; Zazulina, Victoria; Yang, James C.‐H. Journal: Journal of thoracic oncology Issue: Volume 11:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immune checkpoint inhibitors: Navigating a new paradigm of treatment toxicities. Issue 4 (12th July 2017) Authors: Roberts, Kate; Culleton, Vanessa; Lwin, Zarnie; O'Byrne, Kenneth; Hughes, Brett GM Journal: Asia-Pacific journal of clinical oncology Issue: Volume 13:Issue 4(2017) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-term comparative efficacy and safety of nivolumab plus ipilimumab relative to other first-line therapies for advanced non-small-cell lung cancer: A systematic literature review and network meta-analysis. (March 2023) Authors: O'Byrne, Kenneth; Popoff, Evan; Badin, Firas; Lee, Adam; Yuan, Yong; Lozano-Ortega, Greta; Eccles, Laura J.; Varol, Nebibe; Waser, Nathalie; Penrod, John R.; Goring, Sarah Journal: Lung cancer Issue: Volume 177(2023) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗